Not Yet Recruiting OBSERVATIONAL NCT06732362

To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration of Ropivacaine Based on DPN Grading

To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration Ropivacaine Under Ultrasound Guidance Combined With Neurostimulator Based on DPN Grading

Sponsor: Zheng Guo

Conditions Diabetes Mellitus, Type 2

Interventions Different DPN ratings

Updated 2 times since 2025 Last updated: Jul 30, 2025 Started: Aug 20, 2025 Primary completion: Aug 20, 2025 Completion: Oct 29, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06732362, this observational or N/A phase trial focuses on Diabetes Mellitus, Type 2 and remains actively recruiting participants. Sponsored by Zheng Guo, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Not Yet Recruiting
Jan 2025 — Sep 2025 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zheng Guo

Data source: Second Hospital of Shanxi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taiyuan, China